Envveno Medical Corp Stock Performance
| NVNO Stock | USD 10.26 0.02 0.20% |
The firm shows a Beta (market volatility) of 2.8, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, EnVVeno Medical will likely underperform. At this point, enVVeno Medical Corp has a negative expected return of -1.13%. Please make sure to confirm EnVVeno Medical's value at risk, daily balance of power, as well as the relationship between the Daily Balance Of Power and price action indicator , to decide if enVVeno Medical Corp performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days enVVeno Medical Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2026. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
| Begin Period Cash Flow | 3.6 M | |
| Total Cashflows From Investing Activities | 1.3 M |
EnVVeno Medical Relative Risk vs. Return Landscape
If you would invest 2,468 in enVVeno Medical Corp on October 31, 2025 and sell it today you would lose (1,442) from holding enVVeno Medical Corp or give up 58.43% of portfolio value over 90 days. enVVeno Medical Corp is currently does not generate positive expected returns and assumes 7.3962% risk (volatility on return distribution) over the 90 days horizon. In different words, 66% of stocks are less volatile than EnVVeno, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
EnVVeno Medical Target Price Odds to finish over Current Price
The tendency of EnVVeno Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 10.26 | 90 days | 10.26 | about 79.19 |
Based on a normal probability distribution, the odds of EnVVeno Medical to move above the current price in 90 days from now is about 79.19 (This enVVeno Medical Corp probability density function shows the probability of EnVVeno Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.8 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, EnVVeno Medical will likely underperform. Additionally EnVVeno Medical Corp has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. EnVVeno Medical Price Density |
| Price |
Predictive Modules for EnVVeno Medical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as enVVeno Medical Corp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.EnVVeno Medical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. EnVVeno Medical is not an exception. The market had few large corrections towards the EnVVeno Medical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold enVVeno Medical Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of EnVVeno Medical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -1.28 | |
β | Beta against Dow Jones | 2.80 | |
σ | Overall volatility | 4.44 | |
Ir | Information ratio | -0.16 |
EnVVeno Medical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of EnVVeno Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for enVVeno Medical Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| enVVeno Medical Corp generated a negative expected return over the last 90 days | |
| enVVeno Medical Corp has high historical volatility and very poor performance | |
| enVVeno Medical Corp has a very high chance of going through financial distress in the upcoming years | |
| enVVeno Medical Corphas 2,142,698 shares shorted by EnVVeno Medical investors is about 300% of outstending shares | |
| Net Loss for the year was (21.82 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| enVVeno Medical Corp currently holds about 37.48 M in cash with (16.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.96. |
EnVVeno Medical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of EnVVeno Stock often depends not only on the future outlook of the current and potential EnVVeno Medical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. EnVVeno Medical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 14 K | |
| Cash And Short Term Investments | 43.2 M |
EnVVeno Medical Fundamentals Growth
EnVVeno Stock prices reflect investors' perceptions of the future prospects and financial health of EnVVeno Medical, and EnVVeno Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on EnVVeno Stock performance.
| Return On Equity | -0.57 | |||
| Return On Asset | -0.35 | |||
| Current Valuation | (23.45 M) | |||
| Shares Outstanding | 655 K | |||
| Price To Book | 0.23 X | |||
| EBITDA | (21.29 M) | |||
| Cash And Equivalents | 37.48 M | |||
| Cash Per Share | 3.96 X | |||
| Total Debt | 1.06 M | |||
| Debt To Equity | 0.04 % | |||
| Book Value Per Share | 50.98 X | |||
| Cash Flow From Operations | (16.84 M) | |||
| Earnings Per Share | (37.80) X | |||
| Total Asset | 44.95 M | |||
| Retained Earnings | (151.85 M) | |||
About EnVVeno Medical Performance
By examining EnVVeno Medical's fundamental ratios, stakeholders can obtain critical insights into EnVVeno Medical's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that EnVVeno Medical is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California. Envveno Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 24 people.Things to note about enVVeno Medical Corp performance evaluation
Checking the ongoing alerts about EnVVeno Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for enVVeno Medical Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| enVVeno Medical Corp generated a negative expected return over the last 90 days | |
| enVVeno Medical Corp has high historical volatility and very poor performance | |
| enVVeno Medical Corp has a very high chance of going through financial distress in the upcoming years | |
| enVVeno Medical Corphas 2,142,698 shares shorted by EnVVeno Medical investors is about 300% of outstending shares | |
| Net Loss for the year was (21.82 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| enVVeno Medical Corp currently holds about 37.48 M in cash with (16.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.96. |
- Analyzing EnVVeno Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether EnVVeno Medical's stock is overvalued or undervalued compared to its peers.
- Examining EnVVeno Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating EnVVeno Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of EnVVeno Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of EnVVeno Medical's stock. These opinions can provide insight into EnVVeno Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in enVVeno Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Will Stock sector continue expanding? Could EnVVeno diversify its offerings? Factors like these will boost the valuation of EnVVeno Medical. Anticipated expansion of EnVVeno directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every EnVVeno Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding enVVeno Medical Corp requires distinguishing between market price and book value, where the latter reflects EnVVeno's accounting equity. The concept of intrinsic value—what EnVVeno Medical's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push EnVVeno Medical's price substantially above or below its fundamental value.
It's important to distinguish between EnVVeno Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding EnVVeno Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, EnVVeno Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.